Biopharma
Accelerate the Next Wave of Therapeutics
Caris is revolutionizing precision oncology through integration of comprehensive molecular profiling with massive, multimodal datasets to unravel the complexities of cancer.
Caris Biopharma Solutions are designed to empower partners at every stage of the development cycle. With answers that enable more informed program decisions, biopharma partners can increase efficiencies, reduce costs and mitigate risk. These advantages accelerate the development of new therapies and help improve patient lives.
DOCUMENT DOWNLOADS
Product Information
Caris Biopharma Brochure
Caris Discovery® Brochure
Caris Biopharma CDx Brochure
Biopharma Profiling Overview
Biopharma Data Overview
Biopharma Clinical Trials & MI Insights
Biopharma Dealmakers Article
Case Studies
Mulitmodal Data Case Study
Clinical Trial Solutions Case Study
INTEGRATED COMMERCIAL TEAM
Support from ordering to results interpretation
Sales Force Targeting
Enable rapid sales force deployment via biomarker-based alerts for commercial success
MultiModal data LICENSING
Access to Caris databases through collaborative engagements or data licensing models
companion diagnostics
Optimize approaches for developing, validating & launching novel CDx biomarkers
Target ID & Validation
Wet lab and in silico target ID & validation
molecular profiling (solid & liquid)
Comprehensive WES/WTS and select IHC to accelerate development programs with data-driven decisions
trial matching
Accelerate enrollment by identifying biomarker+ patients from Caris commercial cases
digital pathology
Biomarker specific algorithms to
support validation and diagnostics
real-world data ANALYTICS
Utilizing multimodal database to better understand outcomes
Access Deeper Insights for Every Phase of Development
With a multimodal data set that combines deep molecular insights from hundreds of thousands of patients with real-world clinical outcomes, Caris Biopharma Solutions can help inform, empower and optimize every phase of your development.
Inform with insights from the industry’s most comprehensive clinico-genomic database.
- Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS)
- Immunohistochemistry (IHC)
- Matched real-world, molecular and claims data
- Expansive tissue and slide repository
Leverage a Full Suite of Caris Solutions
Gain confidence to make smarter decisions with insight from Caris
Building upon industry-leading, comprehensive molecular profiling in tissue and blood, Caris not only connects patients with therapies and clinical trials, but also connects drug developers with an experienced profiling laboratory infrastructure to support discovery, clinical development, translational medicine and commercialization.
